W2P, yes that just about covers it! Did you know that emails from company officials are not public statements? Perhaps one day soon we will get public confirmation from the company e.g.
DNAPrint™ genomics, Inc. Announces Option Transfer to Beckman Coulter
SARASOTA, Fl, April 1, 2004, DNAPrint™ genomics, Inc. (DNAP) in a stunning surprise announcement today revealed that an Option agreement it had previously signed with Orchid Biosciences, Inc. (Orchid) has been transferred to Beckman Coulter following the acquisition in December 2002 by Beckman of certain assets of Orchid's including SNP (single nucleotide polymorphism) genotyping instruments, bioinformatic software and related consumables business.
DNAPrint™ had the rights to license, sell or partner its products exclusively within the United States and abroad, subject to the terms of the option with Orchid. Under the terms of the agreement, Orchid provided DNAPrint™ an up-front payment for the option to negotiate exclusively for a license to co-develop and/or co-commercialize certain DNAPrint™ products in the future. The agreement provided DNAPrint™ with a potential distribution channel and applied to products DNAPrint™ was currently developing and will develop in the near future.
"We are delighted that the Option has been transferred and are extremely excited about the prospects for DNAPrint™ now that this transfer has taken place," said Richard Gabriel, CEO and President of DNAPrint.
"This transfer marks the start of a new phase of development for the company. DNAPrint™ is now poised to make a significant contribution to the upcoming era of personalized medicine", said Hector J. Gomez, MD, PhD, and Chairman of the Company’s Board.
"This transaction recognizes the value of companies like DNAPrint – companies that are not afraid to take scientific risks, companies that develop technologies that are neglected or unforeseen by others, and companies that devote their efforts to rapidly commercializing products for underserved markets”, said Tony Frudakis, Founder and CSO.
Well maybe not, perhaps they have better things to do with their time...
